| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1345/APH.1P575 |
| P698 | PubMed publication ID | 21521867 |
| P2093 | author name string | Andrew J Muzyk | |
| Allison Chilipko | |||
| Daryn K Norwood | |||
| Jill A Fowler | |||
| P2860 | cites work | Lofexidine, an {alpha}2-receptor agonist for opioid detoxification | Q33521164 |
| Clonidine in alcohol withdrawal | Q33921849 | ||
| Management of alcohol withdrawal delirium. An evidence-based practice guideline | Q34332935 | ||
| Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal | Q34431708 | ||
| The alcohol withdrawal syndrome | Q34711076 | ||
| The pharmacology of chlormethiazole: a potential neuroprotective agent? | Q35981029 | ||
| Management of delirium tremens | Q36124483 | ||
| Sedation and analgesia in the intensive care unit: evaluating the role of dexmedetomidine | Q36692712 | ||
| Dexmedetomidine: an updated review | Q36735205 | ||
| alpha1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol | Q36983396 | ||
| Dexmedetomidine infusion as adjunctive therapy to benzodiazepines for acute alcohol withdrawal | Q37264133 | ||
| Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial | Q37279801 | ||
| Treating agitation with dexmedetomidine in the ICU. | Q37456032 | ||
| An updated focused review of dexmedetomidine in adults | Q37637755 | ||
| Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial | Q38383872 | ||
| Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial | Q38393318 | ||
| NIH conference. Alcohol withdrawal and noradrenergic function | Q39159254 | ||
| Alcohol dependence is independently associated with sepsis, septic shock, and hospital mortality among adult intensive care unit patients. | Q39780554 | ||
| Therapy of alcohol withdrawal syndrome in intensive care unit patients following trauma: results of a prospective, randomized trial | Q40984435 | ||
| Alcohol withdrawal syndromes: clinical management with lofexidine | Q42225170 | ||
| A double-blind randomized placebo-controlled trial of lofexidine in alcohol withdrawal: lofexidine is not a useful adjunct to chlordiazepoxide | Q43721151 | ||
| Dexmedetomidine to facilitate drug withdrawal | Q44293057 | ||
| Changes in plasma noradrenaline and serotonin levels and craving during alcohol withdrawal | Q44414547 | ||
| Alcohol withdrawal syndrome: clinical and hormonal responses to alpha 2-adrenergic agonist treatment | Q45009449 | ||
| Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats | Q45155035 | ||
| Dexmedetomidine for peri-operative sedation and analgesia in alcohol addiction. | Q46946099 | ||
| Alcohol withdrawal: effects of clonidine treatment on sympathetic activity, the renin-aldosterone system, and clinical symptoms | Q48492690 | ||
| Dexmedetomidine as an adjuvant in the treatment of alcohol withdrawal delirium: a case report | Q48684733 | ||
| Dexmedetomidine, diazepam, and propranolol in the treatment of ethanol withdrawal symptoms in the rat. | Q51538142 | ||
| Double-blind study of alprazolam, diazepam, clonidine, and placebo in the alcohol withdrawal syndrome: preliminary findings. | Q51628188 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 649-657 | |
| P577 | publication date | 2011-04-26 | |
| P1433 | published in | Annals of Pharmacotherapy | Q4767858 |
| P1476 | title | Role of α2-agonists in the treatment of acute alcohol withdrawal | |
| P478 | volume | 45 |
| Q38079560 | A case-based approach to the practical application of dexmedetomidine in critically ill adults |
| Q55006460 | Adaptation of the Pharmacological Management of Delirium in ICU Patients in Iran: Introduction and Definition. |
| Q36241022 | Addition of dexmedetomidine to benzodiazepines for patients with alcohol withdrawal syndrome in the intensive care unit: a randomized controlled study. |
| Q36666016 | Adrenergic Inhibition with Dexmedetomidine to Treat Stress Cardiomyopathy during Alcohol Withdrawal: A Case Report and Literature Review |
| Q38062830 | Alcohol withdrawal and delirium tremens in the critically ill: a systematic review and commentary |
| Q41961335 | Alcoholic delirium tremens with hollow viscus perforation scheduled for emergency laparotomy |
| Q58788199 | Anti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational framework |
| Q38620815 | Approach to the Complicated Alcohol Withdrawal Patient. |
| Q52691738 | Central Noradrenergic Interactions with Alcohol and Regulation of Alcohol-Related Behaviors. |
| Q47861743 | Comparison of clinical outcomes in nonintubated patients with severe alcohol withdrawal syndrome treated with continuous-infusion sedatives: dexmedetomidine versus benzodiazepines |
| Q102053756 | Delirium |
| Q90622899 | Delirium Tremens: Assessment and Management |
| Q36297368 | Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICU |
| Q38591896 | Dexmedetomidine for Alcohol Withdrawal Syndrome |
| Q41658188 | Dexmedetomidine for acute baclofen withdrawal. |
| Q38131455 | Dexmedetomidine for the treatment of alcohol withdrawal syndrome: rationale and current status of research |
| Q44837361 | Dexmedetomidine impairs success of patient-controlled sedation in alcoholics during ERCP: a randomized, double-blind, placebo-controlled study |
| Q64915167 | Effectivness of Clonidine in Treating Dexmedetomidine Withdrawal in a Patient with Co-Existing Psychiatric Illness: A Case Report. |
| Q26825434 | Effects of alcohol dependence and withdrawal on stress responsiveness and alcohol consumption |
| Q28266198 | Efficacy and safety of pregabalin in the treatment of alcohol and benzodiazepine dependence |
| Q24608522 | Elevated Norepinephrine may be a Unifying Etiological Factor in the Abuse of a Broad Range of Substances: Alcohol, Nicotine, Marijuana, Heroin, Cocaine, and Caffeine |
| Q38266452 | Evaluating the effects of dexmedetomidine compared to propofol as adjunctive therapy in patients with alcohol withdrawal |
| Q38209048 | Evaluation of dexmedetomidine therapy for sedation in patients with toxicological events at an academic medical center |
| Q39997247 | Genetic Variation in the Vesicular Monoamine Transporter 1 (VMAT1/SLC18A1) Gene and Alcohol Withdrawal Severity |
| Q37161994 | Identification and management of alcohol withdrawal syndrome |
| Q45263185 | Inpatient management of acute alcohol withdrawal syndrome |
| Q39168054 | Involvement of delta opioid receptors in alcohol withdrawal-induced mechanical allodynia in male C57BL/6 mice. |
| Q34613312 | Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes? |
| Q91633412 | Management of Alcohol Withdrawal in the Emergency Department: Current Perspectives |
| Q26778030 | Morphine for Intravenous Patient-Controlled Analgesia May Inhibit Delirium Tremens: A Case Report and Literature Review |
| Q38982604 | Neurobiology of comorbid post-traumatic stress disorder and alcohol-use disorder |
| Q38259371 | Neurochemical mechanisms of alcohol withdrawal. |
| Q34613285 | Novel use of dexmedetomidine for the treatment of anticholinergic toxidrome |
| Q38124469 | Perioperative temperature elevation: not all hyperthermia is malignant hyperthermia |
| Q33582092 | Pharmacological strategies for detoxification |
| Q47791795 | Role of cortical alpha-2 adrenoceptors in alcohol withdrawal-induced depression and tricyclic antidepressants |
| Q64276175 | Sex differences in stress-related alcohol use |
| Q34264716 | The psychopharmacology of agitation: consensus statement of the american association for emergency psychiatry project Beta psychopharmacology workgroup |
| Q36903563 | Treatment of Alcohol Withdrawal Syndrome with and without Dexmedetomidine |
| Q55263124 | Treatment of Severe Alcohol Withdrawal: A Focus on Adjunctive Agents. |
| Q54651541 | [Dexmedetomidine in the treatment of acute alcohol withdrawal delirium]. |
Search more.